Neuronal degeneration and mitochondrial dysfunction

Abstract

Over the last decade, the underlying genetic bases of several neurodegenerative disorders, including Huntington disease (HD), Friedreich ataxia, hereditary spastic paraplegia, and rare familial forms of Parkinson disease (PD), Alzheimer disease (AD), and amyotrophic lateral sclerosis (ALS), have been identified. However, the etiologies of sporadic AD, PD, and ALS, which are among the most common neurodegenerative diseases, are still unclear, as are the pathogenic mechanisms giving rise to the various, and often highly stereotypical, clinical features of these diseases. Despite the differential clinical features of the various neurodegenerative disorders, the fact that neurons are highly dependent on oxidative energy metabolism has suggested a unified pathogenetic mechanism of neurodegeneration, based on an underlying dysfunction in mitochondrial energy metabolism.Mitochondria are the seat of a number of important cellular functions, including essential pathways of intermediate metabolism, amino acid biosynthesis, fatty acid oxidation, steroid metabolism, and apoptosis. Of key importance to our discussion here is the role of mitochondria in oxidative energy metabolism. Oxidative phosphorylation (OXPHOS) generates most of the cell's ATP, and any impairment of the organelle's ability to produce energy can have catastrophic consequences, not only due to the primary loss of ATP, but also due to indirect impairment of "downstream" functions, such as the maintenance of organellar and cellular calcium homeostasis. Moreover, deficient mitochondrial metabolism may generate reactive oxygen species (ROS) that can wreak havoc in the cell. It is for these reasons that mitochondrial dysfunction is such an attractive candidate for an "executioner's" role in neuronal degeneration.The mitochondrion is the only organelle in the cell, aside from the nucleus, that contains its own genome and genetic machinery. The human mitochondrial genome (1) is a tiny 16.6-kb circle of double-stranded mitochondrial DNA (mtDNA) (Figure 1). It encodes 13 polypeptides, all of which are components of the respiratory chain/OXPHOS system, plus 24 genes, specifying two ribosomal RNAs (rRNAs) and 22 transfer RNAs (tRNAs), that are required to synthesize the 13 polypeptides. Obviously, an organelle as complex as a mitochondrion requires more than 37 gene products; in fact, about 850 polypeptides, all encoded by nuclear DNA (nDNA), are required to build and maintain a functioning organelle. These proteins are synthesized in the cytoplasm and are imported into the organelle, where they are partitioned into the mitochondrion's four main compartments -the outer mitochondrial membrane (OMM), the inner mitochondrial membrane (IMM), the intermembrane space (IMS), and the matrix, located in the interior (the organelle's "cytoplasm"). Of the 850 proteins, approximately 75 are structural components of the respiratory complexes ( Figure 2) and at least another 20 are required to assemble and maintain them in working order. The five complexes of the respiratory chain...

Neuronal Inactivation of Peroxisome Proliferator-activated Receptor γ Coactivator 1α (PGC-1α) Protects Mice from Diet-induced Obesity and Leads to Degenerative Lesions

“…Not surprisingly, neurons are exquisitely sensitive to perturbations of mitochondrial function. Impaired mitochondrial energy metabolism has been implicated in numerous heritable neurological disorders as well as neurodegenerative diseases, including Huntington, Parkinson, and Alzheimer disease (51)(52)(53). PGC-1␣ is abundantly expressed in the brain and its deficiency leads to degenerative lesions in several brain regions.…”

The new FDG brain revolution: the neurovascular unit and the default network

“…Indeed, the role of functional imaging with FDG PET would not be so important if the results of two decades of investigation into the molecular genetics and pathophysiology of brain disorders had not clearly demonstrated that degeneration occurs preferentially at the synaptic level and involves dysfunction in mitochondrial energy metabolism [31][32][33]. For this reason, this technique is nowadays considered the most appropriate approach to track local energetic transformation in the living human brain [34].…”

Genetic Ablation of Calcium-independent Phospholipase A2γ Leads to Alterations in Hippocampal Cardiolipin Content and Molecular Species Distribution, Mitochondrial Degeneration, Autophagy, and Cognitive Dysfunction

“…1). Increasing evidence has implicated mitochondrial dysfunction as a critical mechanism underlying the pathologic development of many progressive neurodegenerative disorders, including Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, and Huntington diseases (2)(3)(4)(5)(6).…”

“…In the central nervous system, phospholipase A 2 s (PLA 2 s) 3 play critical roles in cellular growth, lipid homeostasis, and second messenger generation (8,9). PLA 2 s catalyze the cleavage of acyl groups from glycerophospholipids, generating free fatty acids and lysophospholipids, thereby initiating dual pathways of signal transduction (10).…”